Guang Liang
Biographic Data
| ID | 7257604 |
|---|---|
| NAME | Guang Liang |
| GIVEN NAMES | Guang |
| FAMILY NAME | Liang |
| SIGNATURE | LIANG G |
| AFFILIATIONS | Hangzhou Medical College |
| ORCID | 0000-0002-8278-849X |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells
Gigantol
Ganoderic acid A
Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway
In conclusion, this study demonstrated that RK3 promotes learning and cognition in APP/PS1 and C57 mice by promoting neurogenesis and synaptogenesis through the CREB/BDNF signaling pathway. Therefore, RK3 is expected to be further developed into a potential drug candidate for the treatment of Alzheimer's disease (AD)
Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway
Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression
Our findings provide direct evidence that TRAF6 mediates diabetes-induced inflammation leading to renal dysfunction. We also show that KPF is a potential therapeutic agent to reduce inflammatory responses in DN. Also, TRAF6 may represent an interesting target to combat DN
No prominent works on this page.
Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression
Our findings provide direct evidence that TRAF6 mediates diabetes-induced inflammation leading to renal dysfunction. We also show that KPF is a potential therapeutic agent to reduce inflammatory responses in DN. Also, TRAF6 may represent an interesting target to combat DN
Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway
In conclusion, this study demonstrated that RK3 promotes learning and cognition in APP/PS1 and C57 mice by promoting neurogenesis and synaptogenesis through the CREB/BDNF signaling pathway. Therefore, RK3 is expected to be further developed into a potential drug candidate for the treatment of Alzheimer's disease (AD)
Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway
Ganoderic acid A
Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells
Gigantol
Medicine (4 works) · Pharmacology (3 works) · Alzheimer's disease research and treatments (2 works) · Biochemistry (2 works) · Biology (2 works) · Cell Biology (2 works) · Chemistry (2 works) · Internal Medicine (2 works) · Neuroscience (2 works) · Alzheimer's disease (1 works)